Go to Home

Neonatal Intensive Care Biomedical Engineering Research Group (NICeBERG)

Engineering Tomorrow’s Care for Today’s Newborns

About our team

Our research group is dedicated to advancing neonatal care through innovative technologies. We focus on developing automated systems for oxygen delivery tailored to the unique needs of preterm infants and those receiving oxygen therapy in Neonatal Intensive Care Units (NICUs). In addition, we are working on intelligent solutions for the automatic detection and prevention of apnoea, aiming to enhance safety and outcomes in NICU environments. Beyond these core areas, our team explores a range of projects addressing respiratory and oxygen-related challenges in neonatal care. Driven by a passion for improving infant health, we combine engineering, clinical insight, and data science to create impactful solutions for the most vulnerable patients.

Research themes

Research impact

OxyGenie: A global game-changer for preterm babies

One of our key commercialised innovations is the OxyGenie® algorithm, now embedded in the SLE1500 and SLE6000 ventilator systems. OxyGenie® is a closed-loop, automated oxygen control system designed to optimise oxygen delivery for preterm infants in NICUs. By continuously analysing inspired oxygen (FiO₂) and adjusting it in real time, the algorithm helps maintain oxygen saturation (SpO₂) within the target range more effectively than manual control. This not only reduces the need for invasive ventilation but also supports better respiratory outcomes and lowers the risk of oxygen-related complications.

OxyGenie® was honoured with the Queen’s Award for Enterprise: Innovation.

Key grants

  • Automated Titration of Low-flow Oxygen Therapy in Infants and Young Children
    National Health and Medical Research Council-NHMRC Development Grant (2025-2027)
    Grant amount: $1,118,249; This project aims to develop and evaluate a novel device that automates low-flow oxygen delivery for precision targeting of safe oxygen levels in infants and young children needing oxygen therapy.
  • Safer Oxygen Therapy for Preterm Infants Through Automated Oxygen Titration
    National Health and Medical Research Council-NHMRC Investigator Grant (2025-2029)
    Grant amount: $2,462,040; This research program will apply Prof. Dargaville’s patented technology, feedback-controlled automated oxygen titration, across the patient journey, including at the start of life in the delivery room and then partnered with all forms of non-invasive respiratory support.
  • Improved Respiratory Monitoring for Preterm Infants
    Royal Hobart Hospital Research Foundation Grant (2025-2027)
    Grant amount: $449,978; This study aims to develop a novel device for the detection of pauses in breathing resulting from upper-airway obstruction in preterm infants.
  • Neonatal Innovation Simulation Hub Infrastructure Grant
    Menzies Institute for Medical Research, University of Tasmania (2025)
    Grant amount: $120,000; This grant is to fully equip Neonatal Innovation Simulation Hub (NISH) with the cutting-edge technologies for pre-clinical tests including a high-specification Mannequin Paul.

Key collaborations

Universal Safe Oxygen for Newborns (UNISON)

UNISON is an international consortium dedicated to ensuring safe and effective oxygen therapy for all newborns in need. The mission of UNISON is to lead the development of innovative ideas, technologies, and implementation strategies to deliver safe oxygen care for newborns globally.

Find out more about UNISON

Latest news

Join our team

We always looking for talented and passionate students who are eager to develop innovative medical devices that improve neonatal care.

If you're interested in pursuing a PhD or undergraduate (honors) project and contributing to cutting-edge research, please contact Prof. Peter Dargaville, Dr. Tim Gale, Dr. Andrew Marshall or Dr. Ajmal Azees.

Currently available opportunities:

Contact us

Prof. Peter Dargaville (peter.dargaville@utas.edu.au) or Dr. Tim Gale (tim.gale@utas.edu.au).